Navigation Links
Gentech Pharmaceutical Appoints New Medical Director for PhenTabz/ADDTabz
Date:5/22/2012

FORT MYERS, Fla., May 22, 2012 /PRNewswire-iReach/ -- Gentech Pharmaceutical announced today that Dr. Stan Headley has joined the company as Medical Director for its' PhenTabz and ADDTabz products. Dr. Headley brings over 15 years of experience to the world of Integrative Medicine. He holds a Doctorate of Medicine from Spartan Health Science University with clinical training in family medicine at Creighton University School of Medicine and St. Joseph's Hospital in Omaha, Nebraska.

Dr. Headley has served in various capacities in Natural Health as a clinical family medicine practitioner, Chief Medical Officer, Medical Director, Clinical Operations Manager, Natural Products Researcher, Product Training Educator and advocate as a guest speaker on various radio and television programs on Natural Health forums including International radio programs in Puerto Rico and Barbados.

"Dr. Headley's wealth of experience and industry knowledge has already made him a key addition to the Gentech Pharmaceutical family. We are extremely excited to have him as our Medical Director as we continue to grow. Our current products PhenTabz and ADDtabz and new innovations currently in development, paired with increasing demand from our customers led us to look for a skilled professional who understood the incredible opportunities in the field of designer pharmacological alternatives. We have found that professional in Dr. Stan Headley.", says Derek Vest, CEO.

About Gentech Pharmaceutical
Gentech Pharmaceutical applies the science of perfecting and improving current medications and OTC formulations/chemical structures to produce "designer pharmacological alternatives" without the side effects. This unique ability allows Gentech Pharmaceutical to produce the most therapeutically advanced and safe pharmacological products currently available. Gentech shares the most basic and sacred goals of the physicians whom they provide products to: improve the health and well-being of patients with the safest and most effective products available in PhenTabz and ADDTabz.

Press release submitted by SubmitPressRelease123.com

Media Contact: Mike Sharp Gentech Pharmaceutical, 888-666-1714, marketing@gentechpharma.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Gentech Pharmaceutical
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Golden Globe Awards Adds Gentech Pharmaceutical as New Participating Sponsor
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... DUBLIN , Mar. 29, 2017 ... "Orthopedic Navigation Systems Market 2014 - 2025" report to ... ... to reach USD 303.7 million by 2025. Increasing geriatric population ... the demand for orthopedic navigation systems over the forecast period. ...
(Date:3/29/2017)...  Zynex (OTCQB: ZYXI), an innovative medical technology company specializing ... for pain management, stroke rehabilitation, cardiac monitoring and neurological ... 2016 full-year investor webcast on Monday, April 3, 2017 at 9:00 a.m. ... expects to file its 2016 full year financial results ... ...
(Date:3/29/2017)... York , March 29, 2017 ... published a report, which provides an exhaustive study ... the study, nearly 242 companies are functional in ... and competitive. With the leading companies, such as ... Pharma LP, focusing aggressively on various marketing strategies ...
Breaking Medicine Technology:
(Date:3/30/2017)... (PRWEB) , ... March 30, 2017 , ... ... of the Academy of Nutrition and Dietetics (AND), will join nonprofit Seafood Nutrition ... in America,” a live webinar designed to help nutrition educators and students inform ...
(Date:3/29/2017)... ... March 29, 2017 , ... During the last week of March, Chad Kawa, ... eligible individuals in the local community. , Colon cancer is the second leading ... colon cancer while it is small, confined and easier to treat. If you are ...
(Date:3/29/2017)... ... March 29, 2017 , ... The Professional Squash Association, ... enlisted New York City-based sports and entertainment marketing firm Leverage Agency as its ... for the Professional Squash Association (PSA), which includes first-time ever title sponsorship, naming ...
(Date:3/29/2017)... ... ... CHARM CITY RUN WELCOMES MERCY MEDICAL CENTER AS , BALTIMORE WOMEN’S CLASSIC TITLE ... the official title sponsor of the Baltimore Women’s Classic, the largest all women’s 5K ... walk or run the course around the Baltimore Inner Harbor. Mercy has been the ...
(Date:3/29/2017)... ... 30, 2017 , ... Sports Brand EXOUS Bodygear announced today a special sale ... for the remaining days of March, the price will be only $19.97. The EXOUS ... of just $10 (regular retail price $19.97). , The special promotional prices are to ...
Breaking Medicine News(10 mins):